TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia - PubMed (original) (raw)
. 2004 Feb 6;303(5659):848-51.
doi: 10.1126/science.1090922.
Affiliations
- PMID: 14764882
- DOI: 10.1126/science.1090922
Free article
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia
Neil A Bhowmick et al. Science. 2004.
Free article
Abstract
Stromal cells can have a significant impact on the carcinogenic process in adjacent epithelia. The role of transforming growth factor-beta (TGF-beta) signaling in such epithelial-mesenchymal interactions was determined by conditional inactivation of the TGF-beta type II receptor gene in mouse fibroblasts (Tgfbr2fspKO). The loss of TGF-beta responsiveness in fibroblasts resulted in intraepithelial neoplasia in prostate and invasive squamous cell carcinoma of the forestomach, both associated with an increased abundance of stromal cells. Activation of paracrine hepatocyte growth factor (HGF) signaling was identified as one possible mechanism for stimulation of epithelial proliferation. Thus, TGF-beta signaling in fibroblasts modulates the growth and oncogenic potential of adjacent epithelia in selected tissues.
Comment in
- Cancer. Respect thy neighbor!
Radisky DC, Bissell MJ. Radisky DC, et al. Science. 2004 Feb 6;303(5659):775-7. doi: 10.1126/science.1094412. Science. 2004. PMID: 14764858 No abstract available.
Similar articles
- Cancer. Respect thy neighbor!
Radisky DC, Bissell MJ. Radisky DC, et al. Science. 2004 Feb 6;303(5659):775-7. doi: 10.1126/science.1094412. Science. 2004. PMID: 14764858 No abstract available. - Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW, Bhowmick NA. Placencio VR, et al. Cancer Res. 2008 Jun 15;68(12):4709-18. doi: 10.1158/0008-5472.CAN-07-6289. Cancer Res. 2008. PMID: 18559517 Free PMC article. - Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N, Chytil A, Shyr Y, Joly A, Moses HL. Cheng N, et al. Cancer Res. 2007 May 15;67(10):4869-77. doi: 10.1158/0008-5472.CAN-06-3381. Epub 2007 May 10. Cancer Res. 2007. PMID: 17495323 - Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
Pardali K, Moustakas A. Pardali K, et al. Biochim Biophys Acta. 2007 Jan;1775(1):21-62. doi: 10.1016/j.bbcan.2006.06.004. Epub 2006 Jul 8. Biochim Biophys Acta. 2007. PMID: 16904831 Review. - Role of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-β and IGF signaling.
Lee C, Jia Z, Rahmatpanah F, Zhang Q, Zi X, McClelland M, Mercola D. Lee C, et al. Biomed Res Int. 2014;2014:502093. doi: 10.1155/2014/502093. Epub 2014 Jun 25. Biomed Res Int. 2014. PMID: 25089270 Free PMC article. Review.
Cited by
- An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.
Jiang Y, Yu Z, Zheng H, Zhou X, Zhou M, Geng X, Zhu Y, Huang S, Gong Y, Guo L. Jiang Y, et al. Aging (Albany NY). 2024 Jul 8;16(13):10813-10831. doi: 10.18632/aging.205927. Epub 2024 Jul 8. Aging (Albany NY). 2024. PMID: 38980253 Free PMC article. - Tumor-matched and unmatched cancer associated fibroblasts exhibit differential effect on proliferation and FMOD and MMP9 gene expression in head and neck squamous cell carcinoma cells when cocultured in spheroids.
Rademaekers M, Johansson EO, Johansson E, Roberg K, Wiechec E. Rademaekers M, et al. Cancer Cell Int. 2024 May 31;24(1):190. doi: 10.1186/s12935-024-03388-0. Cancer Cell Int. 2024. PMID: 38822309 Free PMC article. - Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities.
Yin N, Li X, Zhang X, Xue S, Cao Y, Niedermann G, Lu Y, Xue J. Yin N, et al. Signal Transduct Target Ther. 2024 May 22;9(1):126. doi: 10.1038/s41392-024-01826-z. Signal Transduct Target Ther. 2024. PMID: 38773064 Free PMC article. Review. - Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer.
Cong Y, Cai G, Ding C, Zhang H, Chen J, Luo S, Liu J. Cong Y, et al. Front Genet. 2024 Apr 17;15:1378907. doi: 10.3389/fgene.2024.1378907. eCollection 2024. Front Genet. 2024. PMID: 38694875 Free PMC article. - Sprouty genes regulate activated fibroblasts in mammary epithelial development and breast cancer.
Li J, Ma R, Wang X, Lu Y, Chen J, Feng D, Zhou J, Xia K, Klein O, Xie H, Lu P. Li J, et al. Cell Death Dis. 2024 Apr 10;15(4):256. doi: 10.1038/s41419-024-06637-2. Cell Death Dis. 2024. PMID: 38600092 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AR41943/AR/NIAMS NIH HHS/United States
- CA102162/CA/NCI NIH HHS/United States
- CA68485/CA/NCI NIH HHS/United States
- CA85492/CA/NCI NIH HHS/United States
- DK46282/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases